×

2016 a lull for health care: Pro

2:12 PM ET Thu, 7 April 2016

Discussing drug pricing, product approvals in the health care industry, and what's to come from the sector, with Matt Maley, Miller Tabak managing director & equity strategist, and Ian Somaiya, BMO Capital biotech analyst.